Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Δ9-tetrahydrocannabinol

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 3, 2006, Pages 1211-1218

  McMahon, Lance R ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL) 1H INDOLE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; COCAINE; DRONABINOL; KETAMINE; MIDAZOLAM; MORPHINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANALYSIS; DRUG ANTAGONISM; DRUG POTENCY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; ANIMALS; BORNANES; CANNABINOIDS; COCAINE; CYCLOHEXANOLS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; KETAMINE; MACACA MULATTA; MALE; MIDAZOLAM; MORPHINE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; TETRAHYDROCANNABINOL;

EID: 33751182888     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.107110     Document Type: Article

References (37)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
2. 9- Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Biobehav Rev 16:55-62.
3. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586-594.
4. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
5. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
6. 9- tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. J Pharmacol Exp Ther 262:479-486.
7. 1). J Pharmacol Exp Ther 289:1427-1433.
8. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
9. 2 cannabinoid receptor mediation of antinociception. Pain 122:36-42.
10. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology 156:369-380.
11. 9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. Eur J Pharmacol 466:121-127.
12. 9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology 140:519-522.
13. 9-THC and (R)-methanandamide in rats. Psychopharmacology 184:36-45.
14. Kenakin T (1997) Pharmacologic Analysis of Drug-Receptor Interaction, Lippincott-Raven Publishers, Philadelphia, PA.
15. Khanolkar AD, Abadji V, Lin S, Hill WA, Taha G, Abouzid K, Meng Z, Fan P, and Makriyannis A (1996) Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J Med Chem 39:4515-4519.
16. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, and Makriyannis A (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769-776.
17. A modulators in rhesus monkeys discriminating midazolam. J Pharmacol Exp Ther 294:902-908.
18. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125-131.
19. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 93:239-245.
20. 9-THC in rhesus monkeys. Behav Pharmacol 16:363-372.
21. McMahon LR, Sell SL, and France CP (2004) Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 308:111-119.
22. Mechoulam R, Shani A, Edery H, and Grunfeld Y (1970) Chem basis of hashish activity. Science (Wash DC) 169:611-612.
23. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
24. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
25. 2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther 290:1222-1229.
26. 1 antagonist, SR 141716A. Behav Pharmacol 7:65-71.
27. Pertwee RG (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond) 30:S13-18.
28. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
29. 2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650.
30. Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis, pp 44-50, Chapman and Hall/CRC, Boca Raton, FL.
31. Tanda G, Munzar P, and Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073-1074.
32. 9- tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend 40:81-86.
33. 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther 275:1-6.
34. 9-tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64:519-522.
35. Wiley JL and Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185-193.
36. Winsauer PJ, Lambert P, and Moerschbaecher JM (1999) Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol 10:497-511.
37. 2 analysis in assessment of opioid abuse liability. Trends Pharmacol Sci 13:282-286.